Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
RATIONALE: Quality-of-life assessment of patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment in patients with cancer.
PURPOSE: This clinical trial studies the quality of life in patients with previously treated ovarian cancer.
Procedure: psychosocial assessment and care
Procedure: quality-of-life assessment
|Official Title:||Quality of Life in Ovarian Germ Cell Cancer Survivors|
|Study Start Date:||April 1999|
|Primary Completion Date:||July 2005 (Final data collection date for primary outcome measure)|
OBJECTIVES: I. Compare quality of life in terms of health status, sexual functioning, psychological/emotional well being, and social functioning in ovarian germ cell cancer survivors vs a matched healthy control group. II. Predict quality of life in these patients through the additive effects of cancer diagnosis and treatment, sociodemographic characteristics, other stressors, and social network variables.
OUTLINE: Patients identify up to 3 healthy acquaintance controls within 3 years of the same age. Patients and controls complete a written questionnaire, which takes about 30 minutes, and a telephone interview, which takes about 1 hour, to assess quality of life.
PROJECTED ACCRUAL: A total of 190 patients and 190 healthy controls will be accrued for this study within 2 years.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00003794
|United States, California|
|Chao Family Comprehensive Cancer Center|
|Orange, California, United States, 92868|
|United States, Illinois|
|Evanston Northwestern Health Care|
|Evanston, Illinois, United States, 60201|
|United States, Indiana|
|Indiana University Cancer Center|
|Indianapolis, Indiana, United States, 46202-5289|
|United States, Texas|
|University of Texas - MD Anderson Cancer Center|
|Houston, Texas, United States, 77030-4009|
|Study Chair:||Stephen D. Williams, MD||Indiana University Melvin and Bren Simon Cancer Center|